IL93034A0 - Recombinant human thyrotropin,its production and its use in diagnostics and treatment - Google Patents

Recombinant human thyrotropin,its production and its use in diagnostics and treatment

Info

Publication number
IL93034A0
IL93034A0 IL93034A IL9303490A IL93034A0 IL 93034 A0 IL93034 A0 IL 93034A0 IL 93034 A IL93034 A IL 93034A IL 9303490 A IL9303490 A IL 9303490A IL 93034 A0 IL93034 A0 IL 93034A0
Authority
IL
Israel
Prior art keywords
diagnostics
treatment
production
recombinant human
human thyrotropin
Prior art date
Application number
IL93034A
Other languages
English (en)
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Publication of IL93034A0 publication Critical patent/IL93034A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
IL93034A 1989-01-11 1990-01-11 Recombinant human thyrotropin,its production and its use in diagnostics and treatment IL93034A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29593489A 1989-01-11 1989-01-11

Publications (1)

Publication Number Publication Date
IL93034A0 true IL93034A0 (en) 1990-11-05

Family

ID=23139856

Family Applications (1)

Application Number Title Priority Date Filing Date
IL93034A IL93034A0 (en) 1989-01-11 1990-01-11 Recombinant human thyrotropin,its production and its use in diagnostics and treatment

Country Status (7)

Country Link
US (8) US6117991A (ja)
EP (1) EP0453482A4 (ja)
JP (1) JPH04501802A (ja)
AU (2) AU648014B2 (ja)
CA (1) CA2045131A1 (ja)
IL (1) IL93034A0 (ja)
WO (1) WO1990008528A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0453482A4 (en) * 1989-01-11 1992-07-22 Us Health Biologically active synthetic thyrotropin and cloned gene for producing same
CA2018676C (en) * 1989-06-20 2003-05-06 Christie A. Kelton Novel heteropolymeric protein production methods
DE19645729C1 (de) * 1996-11-06 1998-06-04 Brahms Diagnostica Gmbh Rezeptorbindungsassay, für den Rezeptorbindungsassay geeigneter rekombinanter Fusionsrezeptor, Vektor zu dessen Herstellung sowie Reagenziensatz für die Durchführung des Rezeptorbindungsassays
GB9909661D0 (en) * 1998-06-06 1999-06-23 Rsr Ltd Assays for TSH receptor autoantibodies
ES2736165T3 (es) 2001-08-23 2019-12-26 Rsr Ltd Regiones epítopo de un receptor de tirotropina (TSH), sus usos y anticuerpos para las mismas
ITRM20030214A1 (it) * 2003-05-05 2004-11-06 Univ Roma Ormone stimolante la tiroide (tsh) radiomarcato e suo uso
WO2005047319A2 (en) * 2003-11-12 2005-05-26 The University Of Georgia Research Foundation, Inc. Dna sequence and expressed recombinant glycoproteins related to feline thyrotropin
EP2018384A2 (en) * 2006-05-17 2009-01-28 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Pyrimidine low molecular weight ligands for modulating hormone receptors
RU2393166C1 (ru) * 2008-12-19 2010-06-27 Ибмед Холдингс Лимитед Олигопептид, стимулирующий пролиферацию фолликулярных клеток щитовидной железы
KR101794289B1 (ko) * 2015-11-05 2017-11-06 주식회사 프로젠 재조합 인간 갑상선 자극 호르몬을 포함하는 조성물 및 상기 재조합 인간 갑상선 자극 호르몬의 정제 방법
KR101789509B1 (ko) * 2015-11-05 2017-10-26 주식회사 프로젠 재조합 인간 갑상선 자극 호르몬을 포함하는 조성물 및 상기 재조합 인간 갑상선 자극 호르몬의 생산 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219538A (en) * 1978-02-06 1980-08-26 Mallinckrodt, Inc. Radioiodination process
US4923805A (en) 1983-11-02 1990-05-08 Integrated Genetics, Inc. Fsh
US4840896A (en) 1983-11-02 1989-06-20 Integrated Genetics, Inc. Heteropolymeric protein
US5156957A (en) 1983-11-02 1992-10-20 Genzyme Corporation Follicle stimulating hormone
JPS6157856A (ja) * 1984-08-29 1986-03-24 Chemo Sero Therapeut Res Inst ホルモンの測定方法
JP2640096B2 (ja) * 1985-07-17 1997-08-13 潔 宮井 新規なヒト甲状腺刺激ホルモンのβサブユニットのＤＮＡ配列
JPS6233200A (ja) * 1985-08-07 1987-02-13 Chemo Sero Therapeut Res Inst モノクロ−ナル抗体
EP0228604A3 (en) * 1985-12-11 1988-10-12 Sloan-Kettering Institute For Cancer Research Isolation of a gene encoding human thyrotropin beta subunit
EP0453482A4 (en) * 1989-01-11 1992-07-22 Us Health Biologically active synthetic thyrotropin and cloned gene for producing same

Also Published As

Publication number Publication date
JPH04501802A (ja) 1992-04-02
AU648014B2 (en) 1994-04-14
WO1990008528A1 (en) 1990-08-09
AU4848090A (en) 1990-08-24
US20010053538A1 (en) 2001-12-20
US20070026464A1 (en) 2007-02-01
AU673866B2 (en) 1996-11-28
EP0453482A1 (en) 1991-10-30
US6284491B1 (en) 2001-09-04
AU5390294A (en) 1994-03-31
US20080107605A1 (en) 2008-05-08
US6117991A (en) 2000-09-12
US20060148005A1 (en) 2006-07-06
US20070190577A1 (en) 2007-08-16
EP0453482A4 (en) 1992-07-22
CA2045131A1 (en) 1990-07-12
US20040132137A1 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
DE3760201D1 (en) (-)-benzhydrylsulfinylacetamide, process for its preparation and its use in therapy
IL91843A0 (en) Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids
HUT50872A (en) Process for producing human interleukin-3 and muteins thereof
EP0330496A3 (en) Skin treatment composition
IL93055A0 (en) Polyimidesiloxanes,their preparation and use
GB2223225B (en) Neutrophil-activating factor: its production and use in treatment
IL81895A0 (en) N-pyridyloxyphenyl-isothioureas,their preparation and their use in pest control
IL112075A0 (en) Recombinant human thymopoietin proteins, their preparation and their medicinal use
EP0453497A4 (en) Treatment methods and vaccines
IL92281A0 (en) Polyimidesiloxanes,their preparation and use
GB8917843D0 (en) Hair treatment
GB8815634D0 (en) Hair treatment
EP0267684A3 (en) Human leukocyte interferon composition and skin treatment
GB8901832D0 (en) Human monoclonal antibody and its production and use
ZA887364B (en) Ovulation treatment
GB9011406D0 (en) Hair-bearing skin area treatment
EP0540575A4 (en) Human meg-csf protein and methods
EG18799A (en) Phenylthioureas, phenylisothioureas and phenylcarbodumides their preparation and use in the control of pests
ZA882852B (en) Pyrrolealdehydes,their preparation and their use
GB2211735B (en) Metoprolol in the treatment and prophylaxis of heart disease
GB9013872D0 (en) Use of protein a and polypeptide components thereof in the treatment of tumours
KR100195373B1 (en) Enzymes which participate in c-terminal amidation, and production and use thereof
ZA89585B (en) Human ifn-beta 2/il-6,its purification and use
IE900202L (en) Skin treatment
ZA887497B (en) Soluble human cd4 fragment and uses therefor